Quotient Sciences Quotient Sciences

X

Digital content for Obsidian Therapeutics

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Obsidian Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
1030 Massachusetts Ave Cambridge, MA 02138
Telephone
Telephone
(781) 806-6245

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.businesswire.com/news/home/20240415417853/en

BUSINESSWIRE
15 Apr 2024

https://www.businesswire.com/news/home/20240409687216/en

BUSINESSWIRE
09 Apr 2024

https://endpts.com/obsidian-therapeutics-raises-160m-for-til-cell-therapy-program/

Lei Lei Wu ENDPTS
03 Apr 2024

https://www.businesswire.com/news/home/20240305665630/en

BUSINESSWIRE
05 Mar 2024

https://www.businesswire.com/news/home/20231212231588/en

BUSINESSWIRE
12 Dec 2023

https://www.businesswire.com/news/home/20230523005283/en

BUSINESSWIRE
23 May 2023

https://endpts.com/maria-fardis-ends-a-two-year-ceo-hiatus-more-leadership-turnover-on-the-menu-at-galapagos/

Alex Hoffman ENDPTS
05 May 2023

https://www.fiercebiotech.com/biotech/bristol-myers-keeps-cell-therapy-obsidian-pact-rocking-multi-year-extension

Nick Paul Taylor FIERCEBIOTECH
27 Oct 2022

https://www.prnewswire.com/news-releases/obsidian-therapeutics-to-present-preclinical-data-from-cytotil15-program-at-the-american-associate-of-cancer-research-aacr-annual-meeting-2022-301522445.html

PRNEWSWIRE
11 Apr 2022

https://www.fiercebiotech.com/biotech/gene-gene-off-chroma-medicine-turns-lights-125m-to-control-gene-expression-ex-editas

K. LaHucik FIERCEBIOTECH
18 Nov 2021
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY